CC0000: The color blue, pantone PMS 302PC, is claimed as a feature of the mark.
D10000: "DENDRITIC NANOTECHNOLOGIES, INC."
DM0000: The mark consists of a sphere representation of a dendrimer with the interior branches in which the sphere is blue and the interior branches are white. In reference to the Pantone commercial color identification system, a shade of blue known as Pantone 302 is used in the sphere.
GS0011: Chemicals, chemical additives, chemical reagents and biochemicals for use in the manufacture of pharmaceutical preparations, medication devices, artificial blood products, electronics, communication hardware, optics, coatings, filters, sensors and lubricants; chemicals, chemical additives, chemical reagents and biochemicals for use in the manufacture of devices for signal amplification, electricity generation, electricity storage, clinical diagnosis, light harvesting, gene transaction and surface decoration; biological diagnostic preparations and reagents for scientific and medical research use; chemical compositions, namely, polyvalent compounds, synthetic molecules and dendrimers for use in the manufacture of pharmaceutical preparations, biological diagnostic preparations, reagents, medication devices, artificial blood products, electronics, communication hardware, optics, coatings, filters, sensors and lubricants; chemical compositions, namely, polyvalent compounds, synthetic molecules and dendrimers for use in the manufacture of devices for signal amplification, electricity generation, electricity storage, clinical diagnosis, light harvesting, gene transfection and surface decoration
GS0421: Biological, pharmaceutical, scientific, industrial, agricultural and chemical research and consultation; product research and development in the fields of chemistry, biology, medicine and veterinary sciences; technical consultation and research in the fields of chemistry, biology, medicine and veterinary sciences; intellectual property consultation and licensing; medical and scientific research, namely, conducting clinical trials; quality control for others
Case File Event Statements
10/10/2014 - 10 years ago
29 - CANCELLED SEC. 8 (6-YR)Type:C8..
3/4/2008 - 17 years ago
28 - REGISTERED-PRINCIPAL REGISTERType:R.PR
1/29/2008 - 17 years ago
27 - LAW OFFICE REGISTRATION REVIEW COMPLETEDType:REGV
1/28/2008 - 17 years ago
26 - ASSIGNED TO LIEType:ALIE
12/17/2007 - 17 years ago
25 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
11/16/2007 - 17 years ago
24 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
11/16/2007 - 17 years ago
23 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
11/16/2007 - 17 years ago
22 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/16/2007 - 17 years ago
21 - NON-FINAL ACTION E-MAILEDType:GNRT
5/16/2007 - 17 years ago
20 - SU - NON-FINAL ACTION - WRITTENType:CNRT
3/27/2007 - 17 years ago
19 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
1/10/2007 - 18 years ago
18 - USE AMENDMENT FILEDType:IUAF
1/10/2007 - 18 years ago
17 - TEAS STATEMENT OF USE RECEIVEDType:EISU
12/12/2006 - 18 years ago
16 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
9/19/2006 - 18 years ago
15 - PUBLISHED FOR OPPOSITIONType:PUBO
8/30/2006 - 18 years ago
14 - NOTICE OF PUBLICATIONType:NPUB
7/27/2006 - 18 years ago
13 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
7/21/2006 - 18 years ago
12 - ASSIGNED TO LIEType:ALIE
7/11/2006 - 18 years ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
7/11/2006 - 18 years ago
10 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
7/11/2006 - 18 years ago
9 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
7/11/2006 - 18 years ago
8 - EXAMINERS AMENDMENT -WRITTENType:CNEA
6/15/2006 - 18 years ago
7 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
6/5/2006 - 18 years ago
6 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
6/5/2006 - 18 years ago
5 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA